HEPION PHARMACEUTICALS INC (HEPA) Stock Income Statement
NASDAQ:HEPA - Nasdaq - US4268974015 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 19.35M | 45.26M | 43.62M | 30.40M | 20.15M | |||
| Research and Development | 11.85M | 35.64M | 33.27M | 20.40M | 12.00M | |||
| Selling, General, and Administrative Expenses | 7.50M | 9.62M | 10.35M | 10.01M | 8.15M | |||
| Operating Income | -19.35M | -45.26M | -43.62M | -30.40M | -20.15M | |||
| Interest Income/Expense | -1.25M | -9.50K | -10.00K | -2.32M | -180.00K | |||
| Other Income/Expense | 4.43M | -877.70K | 410.00K | N/A | N/A | |||
| Non Recurring Items | N/A | -3.19M | -1.87M | N/A | N/A | |||
| Income Before Taxes | -16.16M | -49.34M | -45.08M | -32.72M | -20.32M | |||
| Income Tax | -2.97M | -409.00K | -2.88M | 0.00 | 30.00K | |||
| Net Income | -13.19M | -48.93M | -45.34M | -32.72M | -20.36M | |||
| EBITDA | -19.32M | -45.19M | -43.54M | -30.31M | -20.12M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -107.35 | -12.32 | -11.90 | -9.31 | -42.07 | |||
| Non GAAP EPS | N/A | -616.00 | -590.00 | N/A | -2.53K | |||
| Statistics | ||||||||
All data in USD